Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
39 Leser
Artikel bewerten:
(0)

Global Dental Bone Graft Substitutes and other Biomaterials Market (Natural, Ceramic, Composite and Polymer) - Forecast to 2020

DUBLIN, Oct. 21, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Dental Bone Graft Substitutes and other Biomaterials Market (Natural, Ceramic, Composite and Polymer) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Dental bone graft substitutes and other biomaterials are considered an emerging field of medical science that aims to support growth of natural bone, repair or assist in restoring natural tooth/teeth. To reduce atrophy and increasing adoption rate for better aesthetic look, dental bone grafting is performed on the patients to restore bone to its previous form following gum disease, tooth loss, or trauma. The growth of this market is mainly driven by improving dental reforms in various nations such as U.S. and Australia, across the globe. This helps in increasing dental awareness among patient population coupled with affordability for availing dental services.

Natural segment market accounted for the largest share of total dental bone graft substitutes and other biomaterials market in 2013 and is further segmented as allografts and xenografts. Allografts market has been estimated to account for the largest share of total natural market owing to their wide acceptance among patient population and tissue compatibility post transplantation. In addition, most of the manufacturers are extensively engaged in developing and manufacturing allografts that has also contributed in gaining large market share.

The market for xenografts is anticipated to grow at the highest CAGR of 11.1% during the forecast period 2014 to 2020 owing to increasing preference of tissue banks to collect bone tissues from bovine animals. This is due to the fact that collecting large amount of tissue is easier in case of bovine animal than that of human. Also, shifting trend of population for accepting grafts received from animals is further expected to propel the growth of xenografts market. The global market for dental bone graft substitutes and other biomaterials has been estimated to grow at a CAGR of 10.6% during the forecast period 2014 to 2020.

Increasing number of dental implants and aging population which is more prone to periodontal diseases would accentuate the growth of dental bone graft substitutes and other biomaterials market. In addition, rising incidences of oral problems will also boost the growth of dental bone graft substitutes and other biomaterials market. However, implementation of Affordable Care Act in the U.S. may hamper the overall growth of the market.

Geographically, Europe and North America collectively accounted for more than 70% of the revenue share of the total dental bone graft substitutes and other biomaterials market. This is majorly due to the presence of large number of key players such as Institut Straumann AG and DENSTPLY International in the region. This is due to the presence of opt-in and opts-out scenario in organ and tissue transplantation. Asia-Pacific is expected to grow at the highest CARG during the forecast period owing to rising geriatric population coupled with increasing dental tourism.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Dental Bone Graft Substitutes and other biomaterials Market, by Material

Chapter 5 Dental Bone Grafts Substitutes and Other Biomaterials Market, by Geography

Chapter 6 Recommendations

Chapter 7 Company Profiles

Companies Mentioned:

  • ACE Surgical Supply Company, Inc.
  • BioHorizons IPH, Inc.
  • Biomet, Inc.
  • DENTSPLY International, Inc.
  • DePuy Synthes Companies
  • Geistlich Pharma AG
  • Institut Straumann AG
  • Medtronic, Inc.
  • Zimmer Holdings, Inc.

For more information visit http://www.researchandmarkets.com/research/mhtwh4/dental_bone_graft

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

© 2014 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.